These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 755834)

  • 21. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Gidding HF; Warlow M; MacIntyre CR; Backhouse J; Gilbert GL; Quinn HE; McIntyre PB
    Vaccine; 2007 Dec; 25(51):8637-41. PubMed ID: 18054127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Australia (Au (1)) antigen in Nigerian patients with leprosy.
    Francis TI; Smith JA
    Int J Lepr Other Mycobact Dis; 1972; 40(1):68-72. PubMed ID: 4672997
    [No Abstract]   [Full Text] [Related]  

  • 23. Australia antigen in Down's syndrome patients with Robertsonian translocation.
    Tevaluoto-Aarnio M; Hongell K
    Med Biol; 1974 Feb; 52(1):70-1. PubMed ID: 4283654
    [No Abstract]   [Full Text] [Related]  

  • 24. Australia antigen (a hepatitis-associated antigen) in leukemia.
    Sutnick AI; London WT; Blumberg BS; Yankee RA; Gerstley BJ; Millman I
    J Natl Cancer Inst; 1970 Jun; 44(6):1241-9. PubMed ID: 11515445
    [No Abstract]   [Full Text] [Related]  

  • 25. A study of leprosy in relation with HBsAg.
    Jain AP; Gupta OP; Jajoo UN; Kumar K
    Indian J Lepr; 1984; 56(3):575-7. PubMed ID: 6549326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.
    Kelly TJ; Sanchez TV; Patterson MJ; Mayor GH
    Proc Clin Dial Transplant Forum; 1980; 10():165-8. PubMed ID: 7346842
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevalence of Australia antigen (HBsAg) in patients with Hansen's disease].
    Sarno EN; Azulay DR; Vieira LM; Quadra AA; Barbosa IV; Azulay RD
    AMB Rev Assoc Med Bras; 1980 Dec; 26(12):391-2. PubMed ID: 6973780
    [No Abstract]   [Full Text] [Related]  

  • 28. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological response in leprosy and tuberculosis patients to the 18-kDa antigen of Mycobacterium leprae and antigen 85B of Mycobacterium bovis BCG.
    Vikerfors T; Olcén P; Wiker H; Watson JD
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):571-80. PubMed ID: 8151188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of HBs antigen carriers].
    Kashiwagi S
    Fukuoka Igaku Zasshi; 1989 Aug; 80(8):418-22. PubMed ID: 2583653
    [No Abstract]   [Full Text] [Related]  

  • 31. [Familial hepatocellular carcinoma with positive surface antigen (HBsAg)].
    Sanz Ortiz J; de la Gándara Porres I; Martino E
    Med Clin (Barc); 1985 Dec; 85(20):859. PubMed ID: 3003470
    [No Abstract]   [Full Text] [Related]  

  • 32. Antigens of Mycobacterium leprae in urine during treatment of patients with lepromatous leprosy.
    Olcén P; Harboe M; Warndorff van Diepen T
    Lepr Rev; 1986 Dec; 57(4):329-40. PubMed ID: 3540495
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of hepatitis Bs antigen titres and alpha foetoprotein levels in primary hepatocellular carcinoma in Kenya.
    Bowry TR; Shah MV
    East Afr Med J; 1980 Jun; 57(6):382--9. PubMed ID: 6156817
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis associated antigen (HAA) in leprosy.
    Samuel I; Samuel DR; Godal T
    Ethiop Med J; 1974 Oct; 12(4):175-8. PubMed ID: 4470089
    [No Abstract]   [Full Text] [Related]  

  • 35. [Investigation on human carriage of HBsAg in Qingtian County].
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Apr; 4(2):79-82. PubMed ID: 6883488
    [No Abstract]   [Full Text] [Related]  

  • 36. [Analysis of distribution of antigenic sub-types of viral hepatitis B surface antigen among human population with the method of super-geometrical probability distribution].
    Liu SX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Apr; 3(2):88-90. PubMed ID: 7185452
    [No Abstract]   [Full Text] [Related]  

  • 37. [Observation on dynamics of 131 cases of HBsAg carriers].
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Dec; 4(6):326-8. PubMed ID: 6675853
    [No Abstract]   [Full Text] [Related]  

  • 38. [Distribution of viral hepatitis B infection in Guangsi Province].
    Ding ZR
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Apr; 3(2):84-7. PubMed ID: 7185451
    [No Abstract]   [Full Text] [Related]  

  • 39. [Conversion of HBV serological marker carriers and its influential factors].
    Liu TP
    Zhonghua Liu Xing Bing Xue Za Zhi; 1988 Oct; 9(5):274-7. PubMed ID: 3228854
    [No Abstract]   [Full Text] [Related]  

  • 40. Association between leprosy and hepatitis B infection. A survey in Goiânia, central Brazil.
    Rosa H; Costa AP; Ferraz ML; Pedroza SC; Andrade AL; Martelli CM; Zicker F
    Rev Inst Med Trop Sao Paulo; 1992; 34(5):421-6. PubMed ID: 1342105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.